Exam 2- 6/7 Flashcards

(49 cards)

1
Q

some known vesicants

A

anthracyclines (rubicines, vinca alkaloids, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

anthracylines MOA of tissue destruction

A

DNA binding

  • binds with DNA of surrounding cells
  • most toxic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

vinca alkaloids MOA of tissue destruction

A

non_DNA binding

- cause immediate cell destruction. have a shorter duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

patient-related risk factors for extravasation

A

multiple venipunctures, very young or very old, heavily sedated patients, parathesias, inability to communicate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

prevention strategies

A

central venous catheters, flexible catheters, repeat punctures should be proximal to prior, admin IV push through free flowing IV if given peripherally, check for frequent blood return during infusion, site is important, patient education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

clinical presentation of extravasation

A

local pain and burning, swelling and erythema, lack of blood return, skin ulceration and skin necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sodium bicarb

A

increases pH, increases tissue uptake of anthracyclines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

glucocorticoids

A
  • little to no inflammatory response has been found in tissues with extravasation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

anthracycline extravasation treatment

A

apply cold
- DMSO
- dexrazoxane
(one or the other)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mechlorethamine extravasation treatment

A

appy cold

- 1/6M solution of sodium thiosulfate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

vinca alkaloids extravasation treatment

A
  • apply HEAT

- hyaluronidase: breaks down SQ tissue to increase clearing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

tumors commonly associated with hypercalcemia

A

breast, multiple myeloma, lung, squamous cell cancer of head, neck, esophagus & female genital traction, NHL, leukemia, renal, cervical, colon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

corrected calcium formular

A
  • correct when albumin less than 3.5

Ca+0.8 (4-albumin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

osteolytic HCM

A

metastatic tumor cells release stuff that stimulates osteoclasts, osteoclasts release growth factors that stimular tumor growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

SXS HCM GI:

A

constipation, N/V, anorexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

SXS HCM renal:

A

polyuria, polydipsia, dehydration, decreased GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

SXS HCM neurological

A

lethargy and confusion, irritability, fatigue, muscle weakness, seizures, stupor, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

SXS HCM cardiac

A

shortened QT interval, widened T wave, heart block, asystole, arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

3 basic interventions for HCM

A
  • treat underlying malignancy
  • DC drugs that increase serum Ca or decrease renal blood flow
  • encourage ambulation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

mild HCM treatment

A

Ca less than 12 and asymptomatic

- oral fluids

21
Q

moderate HCM treatment

A

Ca 12-14 and symptomatic

- hydrate + lasix

22
Q

severe HCM treatment

A

Ca 14-16 regardless of symptoms

- treatment+ calcitonin

23
Q

HCM hydration

A
  • NA 200-500ml/hr
  • furosemide
  • reduces Ca by 1.5-2.5; onset 12-24 hours
24
Q

HCM treatment

A
  • bisphosphonates: zoledronic acid (better), pamidronate

- reduces ca by 2-4; onset 48 hours

25
bisphosphonate MOA
- inhibit osteoclast recruitment - induce osteoclast apoptosis - inhibit/reduce osteoclast activity
26
common bisphosphonate toxicity
bone pain, myalgia/arthralgia
27
severe bisphosphonate toxicity
osteonecrosis of the jaw
28
other HCM treatment
add calcitonin for rapid reduction of calcium - reduces Ca by 1; onset 1-4 hours - do not use for mare than 5 days - salmon calcitonin more potent
29
Tumor lysis syndrome (TLS) risk factors
- tumor with high proliferative rate - tumor sensitive to cytotoxic therapy - largetumor masses - leukocytosis - high LDH - pre-existing renal insufficiency - hematologic malignancies
30
cancers with the highest risk of TLS
burkitt's lymphoma, lymphoblastic lymphoma, T cell ALL, AML
31
TLS pathophys
- rapid lysis of tumor cells - release of intracellular content - exceeding ability for normal compensatory mechanism
32
TLS finding
hyperuricemia, hyperkalemia, hyperphosphatemia, hypocalcemia
33
clinical consequences of TLS
- acute renal failure
34
TLS prevention
``` IV hydration alkalinize urine- not recommended allopurinol rasburicase close monitoring ```
35
rasburicase
Elitek - recombinant urate oxidase - uric acid to allantoin
36
rasburicase is contraindicated in
G6PD deficiency
37
rasburicase BBW
anaphylaxis, hemolysis, methemaglobinemia
38
rasburicase dosing
3mg vs 6mg | - use 6mg bc had less need for a repeat dose
39
TLS monitoring
CBC, electrolytes, renal function, urine analysis, fluid intake and output
40
TLS prevention for high risk
hydration , rasburicase
41
TLS prevention for intermediate risk
hydration, allopurinol | - rasburicase may be considered in peds
42
TLS prevention for low risk
clinical judgement and monitoring
43
superior vena cava (SVC) syndrome SXS
dyspnea, tachypnea, cough, venous distension, facial or arm edema, chest pain, dysphagia, sensation of fullness in head, cyanosis
44
causes of SVC syndrome
SCLC, NHL, hodgkins, head and neck cancer, thymoma, germ cell tumors, breast cancer
45
SVC syndrome supportive measures
bed rest, oxygen, corticosteroid, diuretics, low salt diet
46
SVC syndrome treatment
chemo, radiation, surgery, anticoag, thrombotics, catheter removal, stent
47
spinal cord compression clinical presentation
pain | neuro symptoms
48
spinal cord compression treatment
dexamethasone to reduce edema and delay onset of paraplegia
49
treatment of choice for spinal cord compression
radiation